OverviewSuggest Edit

Aiforia (formerly WebMicroscope) is a company specialized in developing intelligent, cloud-based software solutions for digital pathology using artificial intelligence, peep learning technology, and cloud computing. Its novel Aiforia® Cloud brings fast and accurate diagnostics support for pathologists and researchers, removing slow, manual and inconsistent workflow.

HQHelsinki, FI

Latest Updates

Employees (est.) (Jul 2021)35(+7%)
Cybersecurity ratingBMore

Key People/Management at Aiforia

Jukka Tapaninen

Jukka Tapaninen

Chief Executive Officer
Kaisa Helminen

Kaisa Helminen

Chief Operating Officer
Mikael Lundin

Mikael Lundin

Director of Concept Design, Co-Founder
Johan Lundin

Johan Lundin

Chief Scientific Officer, Co-Founder
Kari Pitkänen

Kari Pitkänen

Director of Business Development, Co-Founder
Tuomas Ropponen

Tuomas Ropponen

Chief Technology Officer
Show more

Aiforia Office Locations

Aiforia has offices in Helsinki and Cambridge
Helsinki, FI (HQ)
Tukholmankatu 8
Cambridge, MA, US
One Broadway, 1 Broadway
Show all (2)

Aiforia Financials and Metrics

Summary Metrics

Founding Date


Aiforia total Funding

$38.3 m

Aiforia latest funding size

$30.68 m

Time since last funding

2 months ago

Aiforia investors

Aiforia's latest funding round in June 2021 was reported to be $30.7 m. In total, Aiforia has raised $38.3 m
Show all financial metrics

Aiforia Cybersecurity Score

Cybersecurity ratingPremium dataset



SecurityScorecard logo

Aiforia Online and Social Media Presence

Embed Graph

Aiforia News and Updates

Aiforia appoints Swedbank as lead advisor to explore financing options

HELSINKI, March 15, 2021 /PRNewswire/ -- Aiforia Technologies Oy ("Aiforia" or "the Company") has appointed Swedbank AB (publ) as their lead financial advisor to explore different financing options, including possibilities for an Initial Public Offering (IPO) by listing the Company's...

Aiforia partners with Pathan to bring artificial intelligence assisted diagnostics to the pathology lab

BOSTON, Jan. 21, 2021 /PRNewswire/ -- Pathan, one of the largest pathology laboratories in the Netherlands, has started a collaboration with Aiforia, a leading software company providing artificial intelligence (AI) solutions for medical image analysis. The aim of the partnership is to...

Aiforia enters the clinic with CE-IVD marked product and €2.1M EU Horizon 2020 grant

HELSINKI, Finland, Nov. 18, 2019 /PRNewswire/ -- Aiforia announced today the release of its new product, the CE-IVD marked Aiforia® Clinical, as well as the award of €2.1 million in funding from the EU's Horizon 2020 program. The EU grant was awarded to support Aiforia's ongoing...

Aiforia Blogs

AI in toxicologic pathology: an overview

Toxicologic Pathology Toxicologic pathology, the study of chemicals’ adverse effects on animal models of human diseases, has a significant use in preclinical drug assessment. Toxicologic pathologists are crucial for drug discovery and chemical safety assessments due to their skills in i…

Interview with Pathologist, Dr. Nelli Sjöblom, on AI models aiding chronic cholestasis detection

A cholestatic condition is characterised by a decrease in bile flow as substances normally excreted into bile are retained. Often this is due to impaired hepatocytes or obstruction of bile ducts caused by primary damage to the biliary epithelium.

Introduction to tCECs: a novel method for cancer diagnostics

Cancer Diagnostics Expedited by the COVID-19 pandemic and the disruption it caused to healthcare systems, cancer rates are rising worldwide. Yet, diagnostic methods are finding it difficult to keep up. 

Interview with Emilian Gheorghe on using AI models for breast cancer grading

While breast cancer is a leading cause of cancer death in women worldwide, current approaches for diagnosis and therapy are in need of an upgrade. Early detection and treatment of breast cancer considerably improves outcomes. Hence, many countries have adopted mammography screening progr…

Doctoral student Polina Stepanova discusses benefits of AI in Huntington's Disease image analysis

What is Huntington's Disease? Huntington's disease (HD) is a progressive brain disorder caused by a single defective gene, called huntingtin. Over time this leads to brain damage that causes symptoms such as abnormal involuntary movements, severe cognitive decline, and mood changes. As …

Epredia and Aiforia announce partnership for global distribution of AI-powered pathology software

Portsmouth, NH, USA, June 21, 2021 – Epredia, a global leader in precision cancer diagnostics, and Aiforia, a medical software company providing Artificial Intelligence (AI) based solutions for image analysis in pathology, have announced today that they have entered into a commercial dis…
Show more

Aiforia Frequently Asked Questions

  • When was Aiforia founded?

    Aiforia was founded in 2013.

  • Who are Aiforia key executives?

    Aiforia's key executives are Jukka Tapaninen, Kaisa Helminen and Mikael Lundin.

  • How many employees does Aiforia have?

    Aiforia has 35 employees.

  • Who are Aiforia competitors?

    Competitors of Aiforia include RoomPriceGenie, Redacted and Granulate.

  • Where is Aiforia headquarters?

    Aiforia headquarters is located at Tukholmankatu 8, Helsinki.

  • Where are Aiforia offices?

    Aiforia has offices in Helsinki and Cambridge.

  • How many offices does Aiforia have?

    Aiforia has 2 offices.